Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Genome Engineering

Ben Davies's Biography



Ben Davies, Group Leader, University of Oxford

Dr. Ben Davies received his PhD in molecular biology from the University of Edinburgh where he first encountered gene targeting techniques at the Centre for Genome Research. After a postdoc at the Charite Hospital Berlin, he moved into commercial biotech working as scientific director for a start-up transgenic service company based at the University Hospital Hamburg-Eppendorf which was then merged with the French Biotech company, Genoway. After 4 years in this role, he moved to Oxford where he runs the transgenic core research group at the Wellcome Trust Centre for Human Genetics at the University of Oxford, a position he has held for the last 8 years.

Ben Davies Image

Efficient CRISPR/Cas9 Genome Engineering using Zygotes and Embryos Derived from Cas9 Overexpressing Transgenic Mice

Wednesday, 7 October 2015 at 15:30

Add to Calendar ▼2015-10-07 15:30:002015-10-07 16:30:00Europe/LondonEfficient CRISPR/Cas9 Genome Engineering using Zygotes and Embryos Derived from Cas9 Overexpressing Transgenic MiceGenome Engineering in Hanover, GermanyHanover, GermanySELECTBIOenquiries@selectbiosciences.com

Knock-out and point mutation Knock-in mouse models were efficiency generated by microinjection of oocytes derived from Cas9 overexpressing mice. This genetic supply of Cas9 further simplifies model production using the CRISPR system and led to a significant increase in efficiency.


Add to Calendar ▼2015-10-07 00:00:002015-10-08 00:00:00Europe/LondonGenome EngineeringGenome Engineering in Hanover, GermanyHanover, GermanySELECTBIOenquiries@selectbiosciences.com